Related Experiment Video
Updated: Apr 25, 2026

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
Published on: March 25, 2020
An overview of cholesterol management
Robyn A Burns Schaiff1, Richard M Moe2, Daniel W Krichbaum3
1Senior Director, Regional Medical & Research Specialist, Pfizer, Inc, New York, NY.
Insights
High cholesterol and abnormal lipid profiles significantly increase cardiovascular disease risk. This review covers cholesterol
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Pharmacology
Background:
- Cardiovascular disease (CVD) is the primary global cause of mortality.
- Hypercholesterolemia and dyslipidemia are key modifiable risk factors for CVD.
- Understanding cholesterol's role is crucial for CVD prevention.
Purpose of the Study:
- To elucidate the role of cholesterol in the body.
- To examine the link between cholesterol fractions and CVD risk.
- To outline current dyslipidemia management guidelines and therapeutic strategies.
Main Methods:
- Review of the literature on cholesterol metabolism and CVD.
- Analysis of National Cholesterol Education Program (NCEP) guidelines.
- Discussion of pharmacological treatments for dyslipidemia.
Main Results:
- Different cholesterol fractions (e.g., LDL, HDL) have distinct associations with CVD risk.
- NCEP guidelines provide a framework for assessing and treating dyslipidemia.
- Pharmacological agents vary in mechanism, efficacy, and side effect profiles.
Conclusions:
- Effective management of hypercholesterolemia and dyslipidemia is essential for reducing CVD.
- Therapeutic goals and drug selection should be individualized based on patient risk.
- Continued research into lipid-lowering therapies is warranted.
Abstract:
Cardiovascular disease is the leading cause of death worldwide. Elevated cholesterol (hypercholesterolemia) and abnormal lipid profiles (dyslipidemia) are important risk factors for the development of cardiovascular disease. This article discusses the role of cholesterol in the body and the relationship between different cholesterol fractions and the risk of cardiovascular disease. The guidelines for assessment and treatment of dyslipidemia from the National Cholesterol Education Program are outlined, and cholesterol targets and goals of therapy are discussed. The mechanism of action, place in therapy (eg, first-line, second-line, or add-on), and common side effects are also discussed for each of the available classes of drugs used in the treatment of dyslipidemia.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Angina IV: Management
Lipids: Dietary Sources and Requirements
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

